Safety and Tolerability of the Japanese Encephalitis Vaccine IC51

Clinical trial NCT00605085 · COMPLETED

Trial details

NCT number: NCT00605085
Sponsor: Valneva Austria GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Japanese Encephalitis

Start date: 2005-10-01
Enrollment: 2675

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.